HER2 Support Group Forums - View Single Post - Celldex Therapeutics Presents Positive Results From Phase 2 Study Of The Antibody-Dru

News · 12-19-2009, 04:10 AM

Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced the results of a positive Phase 2 study of CDX-011 (formerly CR011-vcMMAE), in patients with heavily pre-treated, locally advanced or metastatic breast cancers...

More...

12-19-2009, 04:10 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,913	Celldex Therapeutics Presents Positive Results From Phase 2 Study Of The Antibody-Dru Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced the results of a positive Phase 2 study of CDX-011 (formerly CR011-vcMMAE), in patients with heavily pre-treated, locally advanced or metastatic breast cancers... More...